Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
J Ayurveda Integr Med ; 2014 Jan-Mar; 5(1): 50-55
Article in English | IMSEAR | ID: sea-173530

ABSTRACT

Background: Systemic sclerosis (SSc) is a chronic, multisystem connective tissue disorder characterized by autoimmune activation, microvascular endothelium damage, and excessive collagen proliferation. The most affected hand presents claw hand deformity and microvascular disease. Deformed hands can cause functional disability and decrease the quality of life. A daily home program can improve mobility of scleroderma patients. Objective: We sought to determine the effect of a daily home exercise program on hand mobility among scleroderma patients. Materials and Methods: This was a randomized control trial. Twenty-eight participants were divided into two groups, both of which received the same daily home treatment: Group 1 with gloves (n = 14) and Group 2 without gloves (n = 14). The 2-week daily home program combined traditional Thai massage (TTM) with stretching exercises and heat. Hand mobility was assessed using hand mobility in scleroderma (HAMIS). The study was conducted in patients who were already on vasodilator drugs. Results: Both groups showed a signifi cant improvement in hand mobility after 2 weeks of daily home exercise program (P < 0.05). Wearing the glove, however, resulted in better thumb mobility. Conclusions: A daily home exercise program improved hand mobility among patients with scleroderma and wearing gloves may improve thumb mobility.

2.
Article in English | IMSEAR | ID: sea-39858

ABSTRACT

BACKGROUND: Systemic lupus erythematosus (SLE) is a multi-system involvement autoimmune disease that commonly occurs in childbearing age women. During pregnancy and postpartum period, disease activity may be severe or unchanged. Disease flare during pregnancy consistently affects pregnancy outcome. OBJECTIVE: To study pregnancy outcomes and predictive factor for disease flare during pregnancy in SLE patients. MATERIAL AND METHOD: Retrospective descriptive study was performed The study population was pregnant SLE patients who were treated between January 1997 and December 2006 at Department of Obstetrics-Gynecologic and Medicine, Srinagarind Hospital, Khon Kaen University, Thailand. RESULT: The medical records of37 pregnant SLE patients were reviewed Of these, 33 cases gave delivery at Srinagarind Hospital. Mean age was 27.3 +/- 3.26 years, and mean disease duration was 59.67 +/- 38.62 months. Mostly SLE was established before pregnancy; about 10% SLE were firstly recognized during pregnancy During pregnancy, the disease activity was defined active in about two third (25 cases) of the patients. In most cases (60%), disease activity was continued from the pre-pregnancy period. The most common manifestations during pregnancy were lupus nephritis, hemolytic anemia, cutaneous rash, and arthritis respectively. In 40% (10 patients), SLE was severely active but could be controlled with high doses of corticosteroid, two of these required immunosuppressant. Overall live-birth in SLE patients who delivered at Srinagarind Hospital was 72.7%. Among this group, premature labor and intrauterine growth retardation were more commonly found in the patients who had active SLE than who had disease remission throughout pregnancy period with ratio of 4:1 and 7:1 respectively. Pregnancy lost (27.3%) was due to abortion (6 cases) and dead fetus in utero (DFIU; 2 cases) Termination of pregnancy was performed in 10 patients. Indications were severe active lupus (6 cases), DFIU (2 cases), and premature rupture of membrane (1 case). Pregnancy outcome was the best in patients who had inactive disease throughout pregnancy (75%) and worse in groups of patients whose disease flared up (54.5%) or emerged (50%) during pregnancy. CONCLUSION: Even contraception was routinely advised in treating SLE patients, getting pregnant during active disease was eventually found. Lupus nephritis was the most common manifestation. Overall live-birth was 72.7%. Pregnancy lost was due to abortion and dead fetus in utero. Pregnancy outcome was worse in SLE patients who had disease flares up or emerging during pregnancy.


Subject(s)
Adult , Female , Humans , Infant, Newborn , Lupus Erythematosus, Systemic/diagnosis , Pregnancy , Pregnancy Complications/diagnosis , Prenatal Care , Protein Modification, Translational , Young Adult
3.
Article in English | IMSEAR | ID: sea-40316

ABSTRACT

BACKGROUND: Micro-vascular thrombus is a common pathological finding in pulmonary artery hypertension. The association between plasma D-dimer, a marker of thrombus formation, and pulmonary artery hypertension (PAH) in patients with systemic sclerosis is unknown. OBJECTIVE: To assess the correlation of the level of plasma D-dimer and pulmonary artery pressure in patients with systemic sclerosis. MATERIAL AND METHOD: One hundred and twenty nine patients with systemic sclerosis between 19 and 75 years of age (mean, 48 +/- 11.3) entered the study. Plasma D-dimer was determined using immunoturbidimetric assay (D-dimer plus, Dade Behring Inc., Newark, USA). Pulmonary artery pressure was estimated by Doppler echocardiography. PAH was considered present if the Doppler echocardiography-estimated right ventricular systolic pressure (RVSP) exceeded 36 mmHg. RESULTS: Forty-seven patients (36.4%) had PAH according to Doppler echocardiography including 32 (68.1 %) mild (RVSP, 36-45 mmHg), nine (19.1%) moderate (RVSP, 46-55 mmHg), and six (12.8%) severe PAH (RVSP > or = 56 mmHg). No significant correlation was found between plasma D-dimer and RVSP (r = 0. 02, p = 0. 82). CONCLUSION: The present study demonstrated that the D-dimmer level is not associated with the level of pulmonary artery pressure in patients with systemic sclerosis, indicating that microvascular thrombosis may not play a significant role in the pathogenesis of PAH in patients with systemic sclerosis.


Subject(s)
Adult , Aged , Biomarkers , Disease Progression , Female , Fibrin Fibrinogen Degradation Products/analysis , Health Status Indicators , Humans , Hypertension, Pulmonary/diagnosis , Male , Middle Aged , Prospective Studies , Pulmonary Artery/pathology , Risk Assessment , Risk Factors , Scleroderma, Systemic/complications , Severity of Illness Index
4.
Article in English | IMSEAR | ID: sea-39597

ABSTRACT

The authors reported a case of systemic lupus erythematosus (SLE) with an unusual presentation. The patient presented with acute febrile illness along with progressive pancytopenia related to increasing hemophagocytic activity of histiocytes in the bone marrow. Concomitant polyarthritis, myositis, nephritis, high titer of antinuclear factor (1:2,560) and positive test for anti-DNA antibody made him fit the diagnostic criteria of SLE. No definite evidence of associated infections was confirmed by bacteriologic, serologic and viral studies. He did not respond to empiric antibiotic therapy but dramatically responded to corticosteroid treatment. Therefore, diagnosis of acute lupus hemophagocytic syndrome was made. The clinical presentation, laboratory diagnosis, and management of the patient are discussed and the literature was reviewed and presented.


Subject(s)
Acute Disease , Adult , Anti-Inflammatory Agents/therapeutic use , Bone Marrow/pathology , Diagnosis, Differential , Humans , Lupus Erythematosus, Systemic/complications , Male , Pancytopenia/drug therapy , Phagocytosis/immunology , Prednisolone/therapeutic use
5.
Article in English | IMSEAR | ID: sea-45734

ABSTRACT

Tuberculosis, caused by Mycobacterium tuberculosis is a common infection both in immunocompromised and normal hosts. Its clinical manifestation can by divided as pulmonary and extrapulmonary form. Pyomyositis caused by M. tuberculosis is extremely rare. The authors report 2 patients, one with underlying dermatomyositis, and the other with polymyositis. The diagnosis was delayed according to nonspecific symptoms and masking effect of steroid therapy, which led to complications. Microscopy and culture of the pus confirmed the diagnosis. Surgical drainage was done and antituberculous therapy was given. The patient with dermatomyositis was complicated by drug induced hepatitis and died but the other was cured. Tuberculous pyomyositis should be considered in patients who are immunocompromised hosts.


Subject(s)
Adult , Antitubercular Agents/administration & dosage , Dermatomyositis/complications , Fatal Outcome , Follow-Up Studies , Humans , Male , Middle Aged , Mycobacterium tuberculosis/isolation & purification , Polymyositis/complications , Risk Assessment , Treatment Outcome , Tuberculosis/complications
6.
Article in English | IMSEAR | ID: sea-43951

ABSTRACT

Salmonella septic arthritis is an infrequent infectious disease but can cause progressive joint destruction resulting in disability. The authors retrospectively reviewed cases with culture proved Salmonella septic arthritis in Srinagarind Hospital, Khon Kaen from 1994 to 2000. There were 23 episodes in 16 cases; all had underlying diseases and a history of steroid abuse or steroid and immunosuppressive therapy. Systemic lupus erythematosus was the most commonly found underlying disease (56%). Salmonella group D and group B were isolated in 13 and 3 cases. Most first episodes had acute onset of monoarthritis. The antibiotics used as initial treatment of the first episodes were beta lactam, cotrimoxazole or quinolones. There were 8 cases with disabled sequelae and 7 cases with relapse. For 13 evaluable first episodes, relapse occurred in 3 cases in the cephalosporin/penicillin and 4 cases in the cotrimoxazole treated group but none in the quinolones. Six relapse cases were treated successfully with quinolones as well as one with cotrimoxazole. Although 5 relapse cases treated with quinolones had previous progressive joint destruction or avascular necrosis, there was no further joint damage after re-treatment with quinolones. In conclusion, quinolones were more effective than beta-lactams and cotrimoxazole for the treatment of Salmonella septic arthritis to prevent relapse and progressive joint destruction.


Subject(s)
4-Quinolones , Adult , Anti-Infective Agents/therapeutic use , Arthritis, Infectious/complications , Female , Humans , Lupus Erythematosus, Systemic/complications , Male , Middle Aged , Retrospective Studies , Salmonella Infections , Treatment Outcome
7.
Article in English | IMSEAR | ID: sea-39036

ABSTRACT

Kikuchi-Fujimoto's disease (KFD) or histiocytic necrotizing lymphadenitis is a self-limiting condition characterized by fever, neutropenia and lymphadenopathy. It is rarely associated with systemic lupus erythematosus (SLE). The authors reported a case of Kikuchi's necrotizing lymphadenitis who presented with fever, generalized lymphadenopathy, moderate leukopenia, polyarthritis, vasculitis-like lesions and oral ulcers compatible with SLE but serologic tests for autoimmune disease were all negative. The clinical symptoms resolved spontaneously within 3 months without any treatment. Because there is an association between KFD and SLE, great care should be taken with a patient who presents with either KFD or SLE.


Subject(s)
Adult , Histiocytic Necrotizing Lymphadenitis/diagnosis , Humans , Lupus Erythematosus, Systemic/diagnosis , Lymph Nodes/pathology , Male
SELECTION OF CITATIONS
SEARCH DETAIL